HNHongqian Niu

Hongqian Niu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongqian Niu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Supplemental Table 3 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness

    by Matthew R. Dunn, Hongqian Niu, Didong Li, Marc A. Emerson, Caroline A. Thompson, Hazel B. Nichols, Mya L. Roberson, Stephanie B. Wheeler, Terry Hyslop, Jennifer Elston Lafata, et al.

    Supplemental Table 3: Alternate models are shown for delayed and prolonged treatment with stratification (rather than adjustment, as in the main analysis) for patients with stage I, II, or III-IV breast cancer.

  • Open Access

    Supplemental Table 2 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness

    by Matthew R. Dunn, Hongqian Niu, Didong Li, Marc A. Emerson, Caroline A. Thompson, Hazel B. Nichols, Mya L. Roberson, Stephanie B. Wheeler, Terry Hyslop, Jennifer Elston Lafata, et al.

    Supplemental Table 2: Summary of statistical fit criteria (including AIC, BIC, SABIC, entropy, and sample size) used to evaluate optimal number of latent class groups

  • Open Access

    Data from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness

    by Matthew R. Dunn, Hongqian Niu, Didong Li, Marc A. Emerson, Caroline A. Thompson, Hazel B. Nichols, Mya L. Roberson, Stephanie B. Wheeler, Terry Hyslop, Jennifer Elston Lafata, et al.

    Background:Geographic disparities in breast cancer outcomes exist. Few studies have examined community- and health system–level factors associated with care timeliness, an important measure of care quality.Methods:The Carolina Breast Cancer Study is a population-based cohort of 2,998 women with invasive breast cancer (2008–2013). Using latent class modeling, patients’ census tracts of residence were characterized by healthcare accessibility and affordability. Centers for Medicare and Medicaid Services ratings were used to classify hospitals as low- or high-quality. Six timeliness outcomes were assessed: (i) lacking prediagnostic regular care, (ii) being underscreened, (iii) late-stage diagnosis, (iv) delayed treatment initiation, (v) prolonged treatment duration, and (vi) lacking receipt of Oncotype DX genomic testing. Associations of geographic accessibility, healthcare affordability, and hospital-level quality with care timeliness were evaluated with relative frequency differences (RFD) and 95% confidence intervals (CI).Results:Compared with “high-accessibility, high-affordability” census tracts, patients residing in “low-accessibility, low-affordability” areas were more likely to be underscreened (RFD = 18.7%, CI, 13.0, 24.3), have late-stage diagnosis (RFD = 6.2%, CI, 2.4, 10.1), and experience prolonged treatment (RFD = 6.9%, CI, 1.4, 12.3). “High-accessibility, low-affordability” areas had the highest frequency of treatment delay (RFD = 9.3%, CI, 3.9, 14.7). Initial surgery at a high-quality facility was associated with less delayed treatment (RFD = −3.9%, CI, −7.5, −0.4) and prolonged treatment (RFD = −5.9%, CI, −9.9, −1.9).Conclusions:Community- and health system–level factors were associated with timely breast cancer care.Impact:Policy efforts to improve access in communities should consider multiple dimensions of access, including geospatial accessibility and affordability.

  • Open Access

    Supplemental Table 1 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness

    by Matthew R. Dunn, Hongqian Niu, Didong Li, Marc A. Emerson, Caroline A. Thompson, Hazel B. Nichols, Mya L. Roberson, Stephanie B. Wheeler, Terry Hyslop, Jennifer Elston Lafata, et al.

    Supplemental Table 1: Description of care outcomes evaluated in this study, spanning pre-diagnostic (2x), diagnostic (1x), and post-diagnostic (3x) care.

  • Open Access

    Supplemental Figure 1 from Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness

    by Matthew R. Dunn, Hongqian Niu, Didong Li, Marc A. Emerson, Caroline A. Thompson, Hazel B. Nichols, Mya L. Roberson, Stephanie B. Wheeler, Terry Hyslop, Jennifer Elston Lafata, et al.

    Supplemental Figure 1: Cell values are predicted means for variables (normalized by square root transformation) used in the latent class model. Predicted means are conditional given classification into a latent class group (listed along the top row). Reading across a row, a cell with a relatively high value (compared to others in the row) indicates higher frequency of the given characteristic in that latent class group compared to other latent class groups. Ns correspond to the number of North Carolina census tracts in each group.

  • Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness

    by Matthew R. Dunn, Hongqian Niu, Didong Li, Marc A. Emerson, Caroline A. Thompson, Hazel B. Nichols, Mya L. Roberson, Stephanie B. Wheeler, Terry Hyslop, Jennifer Elston Lafata, et al.

    Background: Geographic disparities in breast cancer outcomes exist. Few studies have examined community- and health system–level factors associated with care timeliness, an important measure of care quality. Methods: The Carolina Breast Cancer Study is a population-based cohort of 2,998 women with invasive breast cancer (2008–2013). Using latent class modeling, patients’ census tracts of residence were characterized by healthcare accessibility and affordability. Centers for Medicare and Medicaid Services ratings were used to classify hospitals as low- or high-quality. Six timeliness outcomes were assessed: (i) lacking prediagnostic regular care, (ii) being underscreened, (iii) late-stage diagnosis, (iv) delayed treatment initiation, (v) prolonged treatment duration, and (vi) lacking receipt of Oncotype DX genomic testing. Associations of geographic accessibility, healthcare affordability, and hospital-level quality with care timeliness were evaluated with relative frequency differences (RFD) and 95% confidence intervals (CI). Results: Compared with “high-accessibility, high-affordability” census tracts, patients residing in “low-accessibility, low-affordability” areas were more likely to be underscreened (RFD = 18.7%, CI, 13.0, 24.3), have late-stage diagnosis (RFD = 6.2%, CI, 2.4, 10.1), and experience prolonged treatment (RFD = 6.9%, CI, 1.4, 12.3). “High-accessibility, low-affordability” areas had the highest frequency of treatment delay (RFD = 9.3%, CI, 3.9, 14.7). Initial surgery at a high-quality facility was associated with less delayed treatment (RFD = −3.9%, CI, −7.5, −0.4) and prolonged treatment (RFD = −5.9%, CI, −9.9, −1.9). Conclusions: Community- and health system–level factors were associated with timely breast cancer care. Impact: Policy efforts to improve access in communities should consider multiple dimensions of access, including geospatial accessibility and affordability.